Form 4 for CRDF Cardiff Oncology, Inc.
Accepted 2022-09-20 00:00:00 ET · period of report 2022-09-19 · accession 0001628280-22-025265 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-09-20 | 2022-09-19 | CRDF | White Lale | Dir | P - Purchase | $1.64 | +15.0K | 113.8K | +15% | +$24.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-19 | P | A | 15,000 | $1.64 | 113,788 | I Trust | — | — | (F1) The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.625 to $1.64. Full information regarding the number of shares purcahsed at each separate price can be furnished to the SEC staff upon request. |